Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02179918
Title A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Administration Office Los Angeles California 90095 United States Details
Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles California 90095 United States Details
UCLA Hematology-Oncology Clinic Los Angeles California 90095 United States Details
UCLA Oncology Center Los Angeles California 90095 United States Details
Smilow Cancer Center at Yale-New Haven Hospital New Haven Connecticut 06510 United States Details
Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06510 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
University of Washington Medical Center Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field